The anti-cancer treatment Yescarta was recently approved by the U.S. Food and Drug Administration as a treatment for lymphoma. It’s part of a new approach to combatting blood cancers by re-engineering the immune system.
Karen Weintraub from member station WBUR reports.
Copyright 2020 NPR. To see more, visit https://www.npr.org. 9(MDAyMTYyMTU5MDEyOTc4NzE4ODNmYWEwYQ004))
